Search

everythinglearnresearchcommunity

for

Search:↓

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Hair can regrow after certain stem cells are lost because other stem cells can take over their role.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Minoxidil decreases LH expression, while hydralazine has mixed effects on prolyl and lysyl hydroxylase activities.